Sterling Biotech Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L51900MH1985PLC035738 Incorporated 23 March 1985 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 512299 Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹428.01 Cr
▼ 10.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹2,800 Cr
Registered with MCA
Paid-up capital
₹643.35 Cr
Issued & subscribed
Open charges
₹684.1 Cr
Satisfied ₹21,758 Cr
Company age
41 yrs
Est. 1985
Employees · EPFO
249
Latest available

About Sterling Biotech Limited

Data last updated: 14 July 2026

Sterling Biotech Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Perfect Day Inc.. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 23 March 1985, the company has been in operation for over 41 years.

Registered with ROC Mumbai under CIN L51900MH1985PLC035738. Listed on BSE: 512299.

Capital: an authorised share capital of ₹2,800 Cr and a paid-up capital of ₹643.35 Cr. Formerly known as Sterling Tea & Indutries Limited and Pluto Exports & Consultants Limited. It is led by directors including Monisha Prabhu Macedo and Vishal Jyotindra Gor.

Last AGM: 17 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹428.01 Cr, a decline of 10% compared to the previous year.

The company has a workforce of approximately 249 employees as per the latest available data. It operates as a subsidiary of Perfect Day Inc..

The company is associated with 2 brands - Sterling Gelatin, Sterling Biotech. As per MCA filings, the company has open charges of ₹684.1 Cr and satisfied charges of ₹21,758 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sterlingbiotech.in.

Company Details of Sterling Biotech Limited
CIN L51900MH1985PLC035738
Registration Number 035738
Incorporation Date 23 March 1985
ROC Mumbai
Listing Status Listed (BSE: 512299)
Company Status Active
Date of Last AGM 17 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Perfect Day Inc.
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    201 – 202 Midas Sahar Plaza, Andheri Kurla Road Andheri East, Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, Drug Formulation & Development, API Manufacturers
Company report
Sterling Biotech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sterling Biotech Limited report

Financials, compliance, directors, charges, ownership and filings for Sterling Biotech Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Sterling Biotech Limited

Sterling Biotech Limited has undergone 2 name changes throughout its history. The company was previously known as Sterling Tea & Indutries Limited, and Pluto Exports & Consultants Limited. The current legal name is Sterling Biotech Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Sterling Biotech Limited Current
Sterling Tea & Indutries Limited Previous
Pluto Exports & Consultants Limited Previous

CIN History of Sterling Biotech Limited

Sterling Biotech Limited has one previous CIN (Corporate Identification Number): U51900MH1985PTC035738. The current CIN is L51900MH1985PLC035738, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L51900MH1985PLC035738 Current
U51900MH1985PTC035738 Previous

Associated Brands with Sterling Biotech Limited

Sterling Biotech Limited operates two associated brands: Sterling Gelatin and Sterling Biotech. These brands represent Sterling Biotech Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufacturer and supplier of fermentation based and synthetic APIs sterlingbiotech.in
Gelatin manufacturing and supply operations in Gujarat. sterlinggelatin.com

Competitors & Alternatives of Sterling Biotech Limited

Brands and companies operating in the same space as Sterling Biotech Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Sterling Biotech Limited

Sterling Biotech Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Sterling Biotech Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Sterling Biotech Limited

Sterling Biotech Limited is audited by Deloitte Haskins & Sells for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Deloitte Haskins & Sells Locked Locked Locked
Premium access

Complete auditor history for Sterling Biotech Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Sterling Biotech Limited

Sterling Biotech Limited is currently managed by 6 directors, with 14 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Monisha Prabhu Macedo Nominee Director 24 Mar 2025 1 Years 4 Months Current
Vishal Jyotindra Gor Nominee Director 29 Aug 2024 1 Years 11 Months Current
Keyur Anilkumar Parekh Nominee Director 29 Aug 2024 1 Years 11 Months Current
Alok Kumar Garg Nominee Director 29 Aug 2024 1 Years 11 Months Current
Aftab Mathur Nominee Director 25 Jun 2025 1 Years 1 Months Current
Priyadarshan Kumar Singh Additional Director 24 Mar 2026 0 Years 4 Months Current

Financials of Sterling Biotech Limited FY 2025 filings available

Sterling Biotech Limited reported revenue of ₹428.01 Cr (down 10.00% YoY) for FY 2025.

Revenue · FY 2025
₹428.01 Cr ▼ 10.00%
Premium access

Ten-year financial statements for Sterling Biotech Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Sterling Biotech Limited

Premium access

Shareholding and ownership data for Sterling Biotech Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Sterling Biotech Limited

Open charges
₹684.1 Cr
Satisfied charges
₹21,758 Cr
Breakdown by lending institutions
Others₹667.00 Cr
Hdfc Bank Limited₹14.40 Cr
State Bank of India₹2.70 Cr
Latest charge details
DateLenderAmountStatus
18 Sep 2025 Others ₹572 Cr Open
18 Sep 2025 Others ₹95 Cr Open
28 Nov 2023 State Bank of India ₹2.7 Cr Open
19 Oct 2023 Hdfc Bank Limited ₹14.4 Cr Open
03 Oct 2023 Others ₹24 Cr Satisfied

Total charge records: 83 View all charges

Employees and EPFO Compliance at Sterling Biotech Limited

Sterling Biotech Limited has a workforce of 249 employees as of Mar 27, 2025.

Employee count
249
Active EPFO establishments
2
Employee growth
-32.34%
Premium access

Employee and EPFO history for Sterling Biotech Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Sterling Biotech Limited

Premium access

GST registrations and filing compliance for Sterling Biotech Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Sterling Biotech Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Sterling Biotech Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sterling Biotech Limited

Premium access

MSME payment history for Sterling Biotech Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sterling Biotech Limited

Premium access

Corporate group structure for Sterling Biotech Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sterling Biotech Limited

Premium access

MCA filings and documents for Sterling Biotech Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Sterling Biotech Limited

Directors
01 Apr 2026
Neha Champaben Prajapati was appointed as a Company Secretary on 01 Apr 2026 & has been associated with this company since 4 months 23 days.
Charges
31 Mar 2026
A charge with State Bank Of India of Rs. 2.70 Cr registered on 28 Nov 2023 with Charge ID 100821949 was modified on 31 Mar 2026.
Directors
24 Mar 2026
Priyadarshan Kumar Singh was appointed as a Additional Director on 24 Mar 2026 & has been associated with this company since 5 months.
Charges
05 Mar 2026
A charge with Others of Rs. 572.00 Cr registered on 18 Sep 2025 with Charge ID 101161938 was modified on 05 Mar 2026.
Charges
05 Mar 2026
A charge with Others of Rs. 95.00 Cr registered on 18 Sep 2025 with Charge ID 101161944 was modified on 05 Mar 2026.
Charges
18 Sep 2025
A charge with Others amounted to Rs. 572.00 Cr with Charge ID 101161938 was registered on 18 Sep 2025.

Frequently Asked Questions about Sterling Biotech Limited

Sterling Biotech Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 23 March 1985 (41+ years old) and is registered under CIN L51900MH1985PLC035738. Listed on BSE: 512299. The company has 249 employees.

Sterling Biotech Limited reported revenue of ₹428.01 Cr for FY 2025 (down 10.00% YoY).

The current directors of Sterling Biotech Limited are:

The primary industry of Sterling Biotech Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Sterling Biotech Limited is listed on BSE with code 512299.

Sterling Biotech Limited can be reached at the registered office: 201 – 202 Midas Sahar Plaza, Andheri Kurla Road Andheri East, Mumbai, Maharashtra, India – 400059, or through the website sterlingbiotech.in.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available